𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple primary cancer risk after therapy for Hodgkin's disease

✍ Scribed by Robert S. Brody; Dr. David Schottenfeld; Ann Reid


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
676 KB
Volume
40
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Individualized estimates of second cance
✍ David C. Hodgson; Eng-Siew Koh; Tu Huan Tran; Mostafa Heydarian; Richard Tsang; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 593 KB

## Abstract ## BACKGROUND. Estimates of radiation‐related second cancer risk among Hodgkin lymphoma survivors are largely based on radiation therapy (RT) fields and doses no longer in use, and these estimates do not account for differences in normal tissue dose among individual patients. This stud

The value of gallium imaging after thera
✍ Jeffrey A. Bogart; Chung T. Chung; Neil F. Mariados; Andrei I. Vermont; Sheila M πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 2 views

## Background: Although it is used widely, the value of gallium imaging in managing hodgkin's disease remains unclear. ## Methods: A retrospective review of gallium imaging and treatment outcome in 60 patients with hodgkin's disease treated between january 1990 and july 1995 was conducted. the mi

Treatment failure after primary and salv
✍ Louis L. Pisters πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 42 KB πŸ‘ 1 views

Salvage radical prostatectomy and salvage cryotherapy are greatly underused as potentially curative treatments in patients with recurrent prostate cancer after initial radiation therapy.

Increased risk of colon cancer after ext
✍ Elisabetta Rapiti; Gerald Fioretta; Helena M. Verkooijen; Roberto Zanetti; Franz πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 95 KB πŸ‘ 1 views

## Abstract Radiotherapy can induce second cancers. Controversies still exist regarding the risk of second malignancies after irradiation for prostate cancer. We evaluated the risk of developing colon and rectum cancers after prostate cancer in irradiated and nonirradiated patients. Using data from